Loading viewer...
earnings
Format: PDF earnings
Alembic Pharmaceuticals Limited presented its unaudited financial results for the quarter ended June 30, 2025. The presentation covers Q1 FY2026 performance with forward-looking statements regarding operational and market developments.
annual_report
52 Pages
earnings
32 Pages
Shentel
Cheniere Energy 2016 Q4 & Full Year Earnings Conference
earningsearnings
25 Pages
Cheniere Energy, Inc.
Myriad Genetics Q2 2017 Earnings
earningsearnings
22 Pages
Myriad Genetics
NEXT Biometrics Q2 2022 Earnings Presentation
earningsearnings
14 Pages
NEXT Biometrics Group ASA